From June 24 to 26, the CPHI China exhibition was grandly held at the Shanghai New International Expo Center, drawing widespread attention. Jiudian Pharmaceutical made a remarkable appearance, led by Mr. Fan, Vice General Manager of Jiudian Pharmaceutical and General Manager of Jiudian Hongyang; Ms. Zhu, Operations Director of Jiudian Pharmaceutical; and Ms. Zeng , Director of the International Expansion Department of Jiudian Hongyang. The elite team showcased a diverse product portfolio, highlighting the company’s innovation capabilities and commitment to global development.

Leveraging its strengths in high-quality APIs (active pharmaceutical ingredients) and advanced excipients for injectables and biologics, Jiudian Hongyang demonstrated its differentiated competitive edge at the bustling exhibition booth. New and existing clients from South Korea, Japan, India, Europe, Southeast Asia, Central Asia, Africa, and other regions flocked to explore collaborations. Key APIs such as Flurbiprofen Sodium, Dexketoprofen Trometamol, Diacerein, and Polaprezinc garnered significant interest from high-end markets like Japan and South Korea. Meanwhile, premium excipients, including Calcium Hydrogen Phosphate, Lactose, Kaolin, as well as over 10 injectable-grade excipients like Synthetic Glycerin, Sucrose for Injection, and Maltose for Injection, also attracted considerable attention.

Notably, Jiudian Hongyang has intensified its focus on biological excipients, ensuring end-to-end quality control from R&D to mass production with advanced facilities and stringent standards. Its biological excipients, known for high purity, low bacterial endotoxin levels, and minimal heavy metal content, have gained popularity both domestically and internationally. The company has become a core supplier for leading pharmaceutical firms in China and has successfully entered the supply chains of top pharmaceutical companies in Japan, Russia, India, Egypt, and other countries, steadily advancing its global commercialization strategy.

The International Expansion Department team systematically and professionally introduced the company’s technical advantages in R&D and production, quality control systems, and future strategic plans to visitors. Their confident and insightful presentations not only showcased Jiudian’s capabilities but also reinforced its dedication to advancing global healthcare, earning unanimous praise from attendees and laying a solid foundation for future collaborations.

Jiudian’s Business Cooperation Department brought blockbuster products such as Loxoprofen Sodium Gel Patches to the exhibition, attracting numerous clients from the Middle East, Latin America, the CIS, and Southeast Asia. In-depth discussions were held on market expansion strategies, technical collaboration pathways, and localized registration processes, resulting in multiple partnership agreements. Additionally, the company’s comprehensive CMO service solution, featuring streamlined processes, professional support, and robust resource integration, sparked strong interest among clients, emerging as a new growth engine for Jiudian’s global expansion.

Moving forward, Jiudian will seize the momentum from this exhibition to deepen its "R&D-Driven, Full-Chain Synergy" strategy. By focusing on innovation and integrating resources across R&D, production, sales, and CXO services, the company will further strengthen its presence in pharmaceuticals, APIs, excipients, traditional Chinese medicine, and health products, building a diversified product matrix. Simultaneously, Jiudian will accelerate the development of a global R&D network, partnering with international stakeholders to explore cutting-edge technologies and emerging markets, ensuring faster commercialization of research achievements.

With a commitment to enhancing core product competitiveness and optimizing its full-industry-chain layout, Jiudian will adopt more precise market strategies and bolster its global influence, accelerating the internationalization of Chinese pharmaceutical products. Through these efforts, Jiudian aims to contribute to the prosperity and advancement of the global healthcare industry.